NCAM is a tumour associated antigen expressed on small cell lung cancer, neuroblastoma,
rhabdomyosarkoma, brain tumours, multiple myelomas and acute myeloid leukaemia …

We previously reported a benefit for all-trans retinoic acid (ATRA) in both induction and
maintenance therapy in patients with acute promyelocytic leukemia (APL). To determine the …

Sarcomas are one of the most difficult type of cancer to manage and treat because of their
extremely heterogeneous molecular and morphological features. Despite the progress …

Abstract CD56 antigen, a 200–220 kDa cell surface glycoprotein, identified as an isoform of
the neural adhesion molecules (NCAM), has been found frequently expressed in several …

We investigated the prognostic relevance of immunophenotype and other clinical
pathological features in 379 adult patients with de novo (acute myeloid leukemia) AML …

We report seven cases of particular cutaneous tumors selected from the register of the
French Study Group on Cutaneous Lymphomas. The patients (three men, four women) were …

We have identified and characterized a previously unrecognized form of acute leukemia that
shares features of both myeloid and natural killer (NK) cells. From a consecutive series of …

Background Circulating monocytes may be subdivided according to the presence or
absence of the Fcγ receptor CD16 and the neural cell adhesion molecule CD56. Monocytes …

Flow Cytometry of Hematological Malignancies Flow cytometric analysis is often integral to
the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow …

Abstract G-CSF primed CD34 cells cultured for 2–3 weeks in IL-2 and stem cell factor
generate CD56 high cells with phenotypic and morphologic features of NK cells, and a novel …